{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Moderate+to+Severe+Chronic+Plaque-Type+Psoriasis", "query": { "condition": "Moderate to Severe Chronic Plaque-Type Psoriasis" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 29, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Moderate+to+Severe+Chronic+Plaque-Type+Psoriasis&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-10T13:26:36.299Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01132612", "title": "AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Plaque-type Psoriasis" ], "interventions": [ { "name": "AIN457", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 275, "start_date": "2010-05-11", "completion_date": "2016-10-18", "has_results": true, "last_update_posted_date": "2018-01-04", "last_synced_at": "2026-06-10T13:26:36.299Z", "location_count": 25, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Pasadena, California + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Pasadena", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Newnan", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01132612" }, { "nct_id": "NCT00941031", "title": "AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Plaque-type Psoriasis" ], "interventions": [ { "name": "AIN457", "type": "DRUG" }, { "name": "AIN457A", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 404, "start_date": "2009-07", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2015-08-20", "last_synced_at": "2026-06-10T13:26:36.299Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Pasadena, California + 25 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Pasadena", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Newnan", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00941031" }, { "nct_id": "NCT01412944", "title": "Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Plaque-type Psoriasis" ], "interventions": [ { "name": "secukinumab 150mg", "type": "DRUG" }, { "name": "secukinumab 10mg/kg i.v. regimen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 43, "start_date": "2011-12", "completion_date": "2013-04", "has_results": true, "last_update_posted_date": "2015-03-18", "last_synced_at": "2026-06-10T13:26:36.299Z", "location_count": 6, "location_summary": "Jacksonville, Florida • West Palm Beach, Florida • Boston, Massachusetts + 3 more", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Greensboro", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01412944" }, { "nct_id": "NCT01276639", "title": "A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "CP-690,550", "type": "DRUG" }, { "name": "Placebo/CP-690,550", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 901, "start_date": "2011-03", "completion_date": "2013-04", "has_results": true, "last_update_posted_date": "2014-09-19", "last_synced_at": "2026-06-10T13:26:36.299Z", "location_count": 32, "location_summary": "Birmingham, Alabama • Irvine, California • San Diego, California + 25 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Irvine", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01276639" }, { "nct_id": "NCT02016105", "title": "Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Plaque Type Psoriasis" ], "interventions": [ { "name": "GP2017 Adalimumab", "type": "DRUG" }, { "name": "Humira ® Adalimumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sandoz", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 465, "start_date": "2013-12", "completion_date": "2016-02", "has_results": true, "last_update_posted_date": "2017-05-30", "last_synced_at": "2026-06-10T13:26:36.299Z", "location_count": 69, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Hot Springs, Arkansas + 60 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02016105" }, { "nct_id": "NCT01640951", "title": "4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Moderate to Severe Chronic Plaque-Type Psoriasis" ], "interventions": [ { "name": "AIN457 150 mg", "type": "DRUG" }, { "name": "AIN457 300 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 675, "start_date": "2012-09-16", "completion_date": "2017-05-04", "has_results": true, "last_update_posted_date": "2018-05-25", "last_synced_at": "2026-06-10T13:26:36.299Z", "location_count": 28, "location_summary": "Fresno, California • Pasadena, California • San Francisco, California + 24 more", "locations": [ { "city": "Fresno", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01640951" }, { "nct_id": "NCT01107457", "title": "A Study in Participants With Moderate to Severe Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "Ixekizumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 142, "start_date": "2010-04", "completion_date": "2016-07", "has_results": true, "last_update_posted_date": "2019-09-24", "last_synced_at": "2026-06-10T13:26:36.299Z", "location_count": 31, "location_summary": "Bakersfield, California • New Haven, Connecticut • Washington D.C., District of Columbia + 28 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Miami", "state": "Florida" }, { "city": "Miramar", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01107457" }, { "nct_id": "NCT02660580", "title": "MSB11022 in Moderate to Severe Chronic Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriasis", "Plaque Type Psoriasis", "Moderate to Severe Plaque Psoriasis" ], "interventions": [ { "name": "MSB11022", "type": "DRUG" }, { "name": "Humira®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Fresenius Kabi SwissBioSim GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 443, "start_date": "2016-02-16", "completion_date": "2017-12-18", "has_results": true, "last_update_posted_date": "2023-12-27", "last_synced_at": "2026-06-10T13:26:36.299Z", "location_count": 6, "location_summary": "San Luis Obispo, California • Coral Gables, Florida • West Palm Beach, Florida + 2 more", "locations": [ { "city": "San Luis Obispo", "state": "California" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Dallas", "state": "Texas" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02660580" }, { "nct_id": "NCT01163253", "title": "A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "CP-690,550", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2867, "start_date": "2010-09", "completion_date": "2016-06", "has_results": true, "last_update_posted_date": "2017-06-26", "last_synced_at": "2026-06-10T13:26:36.299Z", "location_count": 101, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Tucson, Arizona + 72 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01163253" }, { "nct_id": "NCT03724292", "title": "An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "VTP-43742", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vitae Pharmaceuticals Inc., an Allergan affiliate", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 40, "start_date": "2015-08-01", "completion_date": "2016-03-08", "has_results": false, "last_update_posted_date": "2018-10-30", "last_synced_at": "2026-06-10T13:26:36.299Z", "location_count": 1, "location_summary": "Fair Lawn, New Jersey", "locations": [ { "city": "Fair Lawn", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT03724292" } ] }